Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Altamura

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Epigenomics|November 7, 2025
The epigenetic mechanisms of ketamine in the treatment of depression: a systematic reviewIvana Leccisotti, Maria Claudia Moretti, Mario Altamura, et al.
Life (Basel, Switzerland)|October 26, 2024
Association of Loneliness with Functional and Cognitive Status in Minor and Major Neurocognitive DisordersMaria Claudia Moretti, Iris Bonfitto, Luciano Nieddu, et al.
Clinical Neuropsychiatry|December 15, 2021
Maladaptive Coping Strategies and Neuroticism Mediate the Relationship Between 5HTT-LPR Polymorphisms and Symptoms of Anxiety in Elite AthletesMario Altamura, Salvatore Iuso, Giovanna D'Andrea, et al.
Neural Regeneration Research|March 27, 2025
Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disordersMadia Lozupone, Ivana Leccisotti, Anita Mollica, et al.
Heart Failure Reviews|August 5, 2019
Delirium in heart failureMichele Correale, Mario Altamura, Raffaella Carnevale, et al.
Expert Opinion on Drug Discovery|April 12, 2023
The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathiesMadia Lozupone, Vittorio Dibello, Rodolfo Sardone, et al.
Journal of Clinical Medicine|July 14, 2023
Personality Traits and Fatigue in Multiple Sclerosis: A Narrative ReviewAlessia Ciancio, Maria Claudia Moretti, Antimo Natale, et al.
Expert Opinion on Drug Discovery|April 30, 2024
Lessons learned from the failure of solanezumab as a prospective treatment strategy for Alzheimer's diseaseMadia Lozupone, Vittorio Dibello, Rodolfo Sardone, et al.
Expert Review of Neurotherapeutics|January 7, 2021
Vitamin D in the development and progression of alzheimer's disease: implications for clinical managementFrancesco Panza, Maddalena La Montagna, Luisa Lampignano, et al.
Frontiers in Aging Neuroscience|June 10, 2022
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's DiseaseFrancesco Bellanti, Vidyasagar Naik Bukke, Archana Moola, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Epigenomics|November 7, 2025
The epigenetic mechanisms of ketamine in the treatment of depression: a systematic reviewIvana Leccisotti, Maria Claudia Moretti, Mario Altamura, et al.
Life (Basel, Switzerland)|October 26, 2024
Association of Loneliness with Functional and Cognitive Status in Minor and Major Neurocognitive DisordersMaria Claudia Moretti, Iris Bonfitto, Luciano Nieddu, et al.
Clinical Neuropsychiatry|December 15, 2021
Maladaptive Coping Strategies and Neuroticism Mediate the Relationship Between 5HTT-LPR Polymorphisms and Symptoms of Anxiety in Elite AthletesMario Altamura, Salvatore Iuso, Giovanna D'Andrea, et al.
Neural Regeneration Research|March 27, 2025
Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disordersMadia Lozupone, Ivana Leccisotti, Anita Mollica, et al.
Heart Failure Reviews|August 5, 2019
Delirium in heart failureMichele Correale, Mario Altamura, Raffaella Carnevale, et al.
Expert Opinion on Drug Discovery|April 12, 2023
The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathiesMadia Lozupone, Vittorio Dibello, Rodolfo Sardone, et al.
Journal of Clinical Medicine|July 14, 2023
Personality Traits and Fatigue in Multiple Sclerosis: A Narrative ReviewAlessia Ciancio, Maria Claudia Moretti, Antimo Natale, et al.
Expert Opinion on Drug Discovery|April 30, 2024
Lessons learned from the failure of solanezumab as a prospective treatment strategy for Alzheimer's diseaseMadia Lozupone, Vittorio Dibello, Rodolfo Sardone, et al.
Expert Review of Neurotherapeutics|January 7, 2021
Vitamin D in the development and progression of alzheimer's disease: implications for clinical managementFrancesco Panza, Maddalena La Montagna, Luisa Lampignano, et al.
Frontiers in Aging Neuroscience|June 10, 2022
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's DiseaseFrancesco Bellanti, Vidyasagar Naik Bukke, Archana Moola, et al.
Pageof 8